Previous close | 8.80 |
Open | 8.93 |
Bid | 8.72 x 400 |
Ask | 8.78 x 200 |
Day's range | 8.59 - 9.00 |
52-week range | 2.55 - 11.27 |
Volume | |
Avg. volume | 723,391 |
Market cap | 846.857M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
ARS Pharmaceuticals ( NASDAQ:SPRY ) First Quarter 2024 Results Key Financial Results Net loss: US$10.3m (loss narrowed...
RA Capital increased its stake in biopharmaceutical firm ARS. Bain Capital lowered its stake in pharmaceutical firm Nuvalent.
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...